No Data
No Data
Have Insiders Sold Applied Therapeutics Shares Recently?
We'd be surprised if Applied Therapeutics, Inc. (NASDAQ:APLT) shareholders haven't noticed that the Chair of the Board of Directors, Shoshana Shendelman, recently sold US$267k worth of stock at US$4.3
Top 4 Health Care Stocks That May Keep You Up At Night This Month
As of June 11, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.The RSI is a momentum indicator
We're Not Very Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate
We can readily understand why investors are attracted to unprofitable companies. Indeed, Applied Therapeutics (NASDAQ:APLT) stock is up 252% in the last year, providing strong gains for shareholders
Applied Therapeutics(APLT.US) 10% Shareholder Sells US$1.27 Million in Common Stock
$Applied Therapeutics(APLT.US)$ 10% Shareholder ALEXANDRIA REAL ESTATE EQUITIES, INC. sold 300K shares of common stock on Jun 4, 5, 2024 at an average price of $4.23 for a total value of $1.27 million
Form 144 | Applied Therapeutics(APLT.US) 10% Stockholder Proposes to Sell 636K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 5, $Applied Therapeutics(APLT.US)$ 10% Stockholder ALEXANDRIA VENTURE INVESTMENTS LLC intends to sell 150K shares of its common stock on Jun 5, with a total market value of
Form 144 | Applied Therapeutics(APLT.US) 10% Stockholder Proposes to Sell 630K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 4, $Applied Therapeutics(APLT.US)$ 10% Stockholder ALEXANDRIA VENTURE INVESTMENTS LLC intends to sell 150K shares of its common stock on Jun 4, with a total market value of
No Data